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Guanosine monophosphate synthetase (GMPS), encoded by guaA gene, is a key enzyme for guanine
nucleotide biosynthesis in Mycobacterium tuberculosis. The guaA gene from several bacterial pathogens
has been shown to be involved in virulence; however, no information about the physiological effect of
direct guaA deletion in M. tuberculosis has been described so far. Here, we demonstrated that the guaA
gene is essential for M. tuberculosis H37Rv growth. The lethal phenotype of guaA gene disruption was
avoided by insertion of a copy of the ortholog gene from Mycobacterium smegmatis, indicating that this
GMPS protein is functional in M. tuberculosis. Protein validation of the guaA essentiality observed by PCR
was approached by shotgun proteomic analysis. A quantitative method was performed to evaluate
protein expression levels, and to check the origin of common and unique peptides from M. tuberculosis
and M. smegmatis GMPS proteins. These results validate GMPS as a molecular target for drug design
against M. tuberculosis, and GMPS inhibitors might prove to be useful for future development of new
drugs to treat human tuberculosis.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The causative agent of tuberculosis (TB), Mycobacterium tu-
berculosis, infects one-third of the world population. The World
Health Organization estimates that 9 million new TB cases oc-
curred in 2013, resulting in 1.5 million deaths, of which 360,000
were HIV-positive individuals, and approximately 210,000 were
people infected with multidrug-resistant strains [1]. The emer-
gence of drug-resistant strains and the global spread of HIV are
aggravating factors related to this infectious disease. Thus, there is
a critical need for the development of new drugs and vaccines toB.V. This is an open access article u
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.decrease TB incidence worldwide.
Understanding the role of enzymes involved in the metabolic
pathways ofM. tuberculosis is crucial to identify targets for rational
drug and vaccine designs. Enzymes involved in the purine bio-
synthesis pathways have important roles in cellular metabolism,
as they provide nucleotides that are essential components of a
number of biomolecules [2]. Guanosine monophosphate synthe-
tase (EC 6.3.5.2) (GMPS), encoded by guaA gene (Rv3396c), cata-
lyzes the conversion of xanthosine 5′-monophosphate (XMP) into
guanosine 5′-monophosphate (GMP), and is a key enzyme in both
purine de novo and salvage pathways of guanine nucleotides [3].
The guaA gene from several bacterial pathogens has been
shown to be involved in virulence. Deletion of guaA gene from
Francisella tularensis, the infectious agent of tularemia, resulted in
a guanine auxotrophic strain that was highly attenuated in a
mouse model of infection, and failed to replicate in macrophages
[4]. Similarly, the construction of a deletion mutation in the guaBA
operon of Shigella ﬂexneri generated a guanine auxotrophic strainnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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operon was also reported to be essential for survival and in-
fectivity of Borrelia burgdorferi, the causative agent of Lyme bor-
reliosis [6]. Unlike other bacteria, guaA and guaB genes are located
in different loci within M. tuberculosis genomic DNA. Both guaB2
(Rv3411c, encoding inosine monophosphate dehydrogenase,
IMPDH) and guaA genes were predicted to be essential for M. tu-
berculosis growth in previous high density mutagenesis studies
[7,8]. The biochemical characterization of M. tuberculosis GMPS
(Mtb-GMPS) has been recently published [3]; however, no in-
formation on the physiological effect of direct guaA disruption in
M. tuberculosis has been described so far.
Therefore, in this study we aimed to evaluate the essentiality of
guaA by gene replacement in M. tuberculosis H37Rv strain. The
evidence of essentiality was conﬁrmed at protein level via LC–MS/
MS through Multidimensional Protein Identiﬁcation Technology
(MudPIT) analysis of M. tuberculosis cellular extracts. Multiplexed
quantitative LC–MS/MS analysis with isotopic dimethyl labeling
was performed to validate protein expression levels, and to con-
ﬁrm the origin of shared and unique peptides from both gene
products.2. Materials and methods
2.1. Construction of the suicide delivery vector
A fragment of 2577 bp containing the guaA gene (1518 bp) with
its ﬂanking region was ampliﬁed by polymerase chain reaction
(PCR) from M. tuberculosis H37Rv genomic DNA, using primers
forward (5′-tttttctagaggacccgtcagcacggcgac-3′) and reverse (5′-
tttttctagattgtcgacgcgcccacattgca-3′), both containing XbaI restric-
tion sites (underlined). The 2577 bp fragment was subsequently
cloned into pUC19 using the XbaI restriction site. The guaA gene
was disrupted by the insertion of a kanamycin cassette from
pUC4K into unique internal restriction enzymes sites NheI and
AscI, releasing a fragment of 719 bp from guaA gene (Fig. 1). Insert
was released from pUC19 derivative vector by digestion with XbaI,
and subcloned into XbaI linearized pPR27xylE vector [9].
2.2. Construction of the complementing vector
The ortholog guaA gene fromMycobacterium smegmatismc2155
(MSMEG_1610), ﬂanked by about 200 bp upstream and 100 bp
downstream, was ampliﬁed by PCR from M. smegmatis genomic
DNA using primers forward (5′-tttttctagagccgtccaggtcgaacaggca-
3′) and reverse (5′-tttttctagaacccacgagcagcgaacaatt-3′), both con-
taining XbaI restriction sites (underlined), and was cloned intoFig. 1. Genomic environment of guaA gene inM. tuberculosis (A) and regions cloned
into pPR27xylE vector (B). A. Genomic region of guaA gene (1.578 kb) containing
unique internal NheI and AscI sites and ﬂanking genes. B. The guaA gene and
ﬂanking regions were ampliﬁed by PCR from M. tuberculosis H37Rv genomic DNA
using primers forward and reverse both containing XbaI restriction sites. The guaA
gene was disrupted by the insertion of a kanamycin cassette (kanR) into NheI and
AscI sites (guaA::kanR), releasing a fragment of 719 bp. The guaA::kanR fragment
was cloned into pPR27xylE vector.XbaI linearized pNIP40/b, a mycobacteriophage Ms6-derived in-
tegrative vector [10].
2.3. Generation of a strain containing disrupted guaA gene
M. tuberculosis H37Rv strain was transformed by electropora-
tion with approximately 2 mg of suicide delivery vector construc-
tion. Bacteria were plated on Middlebrook 7H10 10% OADC con-
taining 25 mg/mL kanamycin, and incubated at 32 °C. After
6 weeks, 1% catechol was dropped on colonies to select those
containing the plasmid. Six different yellow colonies were picked
up from the transformant, and cultivated in Middlebrook 7H9 10%
OADC 0.05% tween-80 with 25 mg/mL kanamycin at 32 °C. In-
dividual cultures were plated on Middlebrook 7H10 10% OADC
containing 25 mg/mL kanamycin, 2% sucrose, and cultivated at
39 °C. Clones were also plated on solid media containing 20 mg/mL
of guanine to evaluate the presence of guanine auxotrophic co-
lonies. After 6 weeks, 1% catechol was dropped on colonies to
select those that might be double crossover (DCO) strains. The
white colonies were inoculated in liquid media containing
25 mg/mL kanamycin, and cultivated at 37 °C for 3 weeks. Genomic
DNA was isolated and PCRs were carried out using gene-speciﬁc
screening primers forward (5′-gcccgtatggaaatcgactg-3′) and re-
verse (5′-actatcgcactaaccggcac-3′) to determine whether the wild-
type or the disrupted guaA gene was present in the targeted
chromosomal region.
2.4. Generation of complemented strain
In order to obtain the complemented strain with the guaA gene
from M. smegmatis, M. tuberculosis H37Rv was transformed by
electroporation with about 2 mg of the complementing vector
construction. Bacteria were plated on Middlebrook 7H10 10%
OADC containing 50 mg/mL hygromycin, and incubated at 37 °C.
After 3 weeks, a single colony was cultivated in 5 mL Middlebrook
7H9 10% OADC 0.05% tween-80 with 50 mg/mL hygromycin at
37 °C, subcultivated in 50 mL of the same medium, and electro-
competent cells were prepared. The M. tuberculosis strain con-
taining the complemented vector integrated on its genomic DNA
was transformed by electroporation with about 2 mg of suicide
delivery vector construction. The following steps to obtain the
complemented strain were carried out as described above for the
generation of a strain containing the guaA gene disrupted, with the
addition of 50 mg/mL hygromycin on culture medium.
2.5. Protein extraction
Wild-type H37Rv and complemented strains were grown in
50 mL Middlebrook 7H9 10% OADC 0.05% tween-80 containing the
proper antibiotics up to an OD600 of 0.5–0.7. Cellular pellets were
washed twice using 10 mM Tris HCl pH 8.0. Cells were re-
suspended in 1 mL of the same buffer containing protease in-
hibitor cocktail (Promega), and then transferred to 2 mL lysing
matrix B tubes containing 0.1 mm diameter silica beads (MP Bio-
medicals). Cells were disrupted by using a L-Beader 3 (Loccus
Biotecnologia) at a speed setting of 4000 rpm, 10 cycles of 30 s
each, cooling between cycles. After lysis, the cell free supernatants
were collected by centrifugation at 2300g for 5 min at room
temperature. The supernatants were ﬁltered through 0.22 μm
Millex Durapore ﬁlters (Millipore). Protein concentrations were
measured using the bicinchoninic acid assay (Pierce).
2.6. Liquid chromatography and tandem mass spectrometry (LC–MS/
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2.6.1. In solution digestion
Chloroform/methanol protein precipitation was performed in
cellular extracts (200 mg) from wild-type and complemented
strains, according to Wessel and Flügge [11]. Protein pellets were
resuspended in 100 mM tris (hydroxymethyl) aminomethane
(Tris) HCl pH 8.5 containing 8 M urea, and digested with a protocol
adapted from Klammer and MacCoss [12]. Brieﬂy, disulﬁde bonds
were reduced in 5 mM dithiothreitol (DTT) for 20 min at 37 °C and
then cysteines were alkylated in 25 mM iodoacetamide (IAM) for
20 min at room temperature in the dark. Urea was diluted to 2 M
with 100 mM Tris, and the complex protein extract was digested
with trypsin in a ratio of 1:100 enzyme/protein along with 1 mM
CaCl2 by overnight incubation at 37 °C. Formic acid was added to
ﬁnish the reaction (5% v/v, ﬁnal concentration).
2.6.2. Stable isotope dimethyl labeling
For dimethyl labeling, cellular extracts were submitted to the
digestion protocol described above, using triethylammonium bi-
carbonate (TEAB) buffer instead of Tris. After overnight trypsin
digestion, samples were stored at 20 °C without addition of
formic acid. Isotopic dimethyl labeling reactions were performed
as described by Boersema et al. [13]. Peptides (100 mg) were la-
beled at free-amines (N-terminus and lysine side chain), by com-
bining isotopic forms of formaldehyde and sodium cyanoborohy-
dride, resulting in mass shifts of þ28.0313 Da (Light:
CH2OþNaBH3CN), þ32.0564 Da (Intermediate: CD2OþNaBH3CN),
or þ36.0757 Da (Heavy: 13CD2OþNaBD3CN) per incorporated la-
bel. Wild-type cellular extract sample (containing Mtb-GMPS) was
labeled as “Light”, a mix of equal amounts of wild-type and
complemented cellular extracts (containing M. smegmatis GMPS,
Msm-GMPS) was labeled as “Intermediate”, and complemented
cellular extract sample was labeled as “Heavy”.
2.6.3. LC–MS/MS and MudPIT
Samples were analyzed in technical triplicates via LC–MS/MS.
Chromatographic separations were performed on an Eksigent
nanoLC Ultra 1D plus autosampler (currently part of AB Sciex)
connected to a LTQ-XL Orbitrap Discovery hybrid instrument
(Thermo Fisher Scientiﬁc) through a nanoeletrospray ion source
(Thermo Fisher Scientiﬁc). Pre-columns and biphasic MudPIT col-
umns (150 mm ID/360 mm OD fused-silica capillary) were prepared
in house by slurry packing 2 cm of C18 reversed phase resin (5 mm
ODS-AQ C18 Yamamura Chemical Lab) and 2.5 cm of SCX resin
(5 mm Partisphere, Whatman) followed by 2.5 cm of C18 reversed
phase material, respectively. Capillary analytical columns (100 mm
ID/360 mm OD capillary) were slurry packed with 20 cm of C18
reversed phase packing material behind a 5 mm ID tip.
Five micrograms of either wild-type or complemented cellular
extracts were injected through the autosampler at 1 mL/min for
15 min. Mobile phases were water/acetonitrile/formic acid (95:5:0.1)
as buffer A, and water/acetonitrile/formic acid (10:90:0.1) as buffer B.
Gradient elution was 6 h long at 300 nL/min as follows: 0–5% B in
5 min; 5–25% B in 20 min; 25–50% B in 25 min; 50–80% B in 30 min;
80% B for 5 min; 80–0% B in 1 min; 5% B for 14 min.
MudPIT analysis was carried out according to Wolters et al.
[14]. Light, Intermediate and Heavy samples were mixed in equal
proportions (25 mg each) and pressure-loaded into a biphasic col-
umn. MudPIT consisted of one transfer step followed by 10 buffer C
(500 mM ammonium acetate in buffer A) injections (10, 20, 30, 50,
60, 70, 85, 100% C and 90% C/10% B twice) and the reversed phase
elution gradients. Transfer step gradient was 1 h long at 300 nl/
min as follows: 0–10% B in 3 min; 10–50% B in 39 min; 50–90% B in
5 min; 90% B for 2 min; 90–0% B in 1 min; 0% B for 10 min. Elution
gradients were 2 h long at 300 nl/min as follows: 0–5% B in 5 min;5–25% B in 60 min; 25–50% B in 40 min; 50–80% B in 25 min; 80%
B for 5 min; 80–0% B in 1 min; 5% B for 14 min.
Data were collected with one FT full-scan (400–1600 m/z
range; 30,000 resolution) followed by data dependent CID MS/MS
spectra of the 8 most intense ions in the ion trap, with dynamic
exclusion (1 repeat count, 30 s repeat duration, 100 exclusion list
size, and 30 s exclusion duration). The mass spectrometer and
HPLC were controlled by the Xcalibur data system (Thermo Fisher
Scientiﬁc).3. Data analysis
Tandem mass spectra were searched from RAW ﬁles with the
software Comet [15] in the PatternLab for Proteomics platform
[16]. The database contained a non-redundant M. tuberculosis
H37Rv reference proteome (Proteome ID UP000001584, www.
uniprot.org), the Msm-GMPS sequence (MSMEG_1610, www.uni-
prot.org), and reverse sequences of all entries. Search space in-
cluded all fully and semitryptic peptide candidates. Carbamido-
methylation of cysteine was considered as static modiﬁcation. The
validity of the peptide spectra matches (PSMs) was assessed using
the module Search Engine Processor (SEPro, PatternLab for Pro-
teomics), with a false discovery rate of 1%.
For the dimethyl labeled samples, protein and peptide identi-
ﬁcation and quantiﬁcation were carried out in Integrated Pro-
teomics Pipeline-IP2 (Integrated Proteomics Applications, Inc.,
http://www.integratedproteomics.com). Tandem mass spectra
were extracted from RAW ﬁles using RawXxtract 1.9.9.2 [17] and
searched with ProLuCID v.1.3.1 [18], including fully and semitryptic
peptide candidates, using carbamidomethylation of cysteine as
static modiﬁcation, and light, intermediate and heavy forms of
dimethylation as metabolic modiﬁcations. Peptide candidates
were ﬁltered using DTASelect 2.0 [19]. Quantitative analysis of the
entire proteome was performed by Census integrated into IP2 pi-
peline [20]. Mtb-GMPS and Msm-GMPS ratios were calculated
using Qual Browser from Thermo XCalibur 2.2 (Thermo Fisher
Scientiﬁc) and Skyline [21].4. Results
GMPS activity was shown to be essential for M. tuberculosis
growth in previous high density mutagenesis studies [7,8]. In or-
der to directly evaluate GMPS essentiality, a genetic strategy using
the pPR27xylE vector was employed to disrupt the functional guaA
gene from the chromosome of M. tuberculosis H37Rv. The
pPR27xylE vector contains the counter-selective sacB gene, the
reporter gene xylE, and a mycobacterial thermosensitive origin of
replication, which enable the selection of mutants in M. tubercu-
losis [9]. The genomic environment of guaA gene and the regions
used to construct the suicide delivery vector are shown in Fig. 1.
The pPR27xylE construction containing the guaA gene disrupted by
a selection marker was introduced into the M. tuberculosis H37Rv
strain; six recombinant yellow colonies were selected. In the next
step, all the possible DCO white colonies obtained on plates, either
containing guanine or not, were inoculated on liquid media, their
genomic DNAs extracted and PCRs carried out using gene-speciﬁc
primers to determine whether the wild-type or the disrupted guaA
gene was present. Of the 17 potential DCOs screened, all were
wild-type for the guaA gene either from plates containing guanine
or not (Fig. 2A and B). This result is an indication that the guaA
gene is essential for M. tuberculosis growth in the experimental
conditions employed.
In order to conﬁrm guaA essentiality in M. tuberculosis, a strain
carrying a copy of the ortholog guaA gene from M. smegmatis
Fig. 2. The guaA gene is essential for M. tuberculosis growth. A. Expected PCR product sizes using gene-speciﬁc screening primers forward (F) and reverse (R) for strains
containing guaA gene either wild-type or disrupted. B. Agarose gel electrophoresis of PCR products from possible double crossover (DCO) strains which were transformed
with pPR27xylE::guaA Kan. Among 17 screened clones, 2 representative clones are shown. M – molecular marker 1 kb plus DNA Ladder (Invitrogen), PCRs were carried out
with: Lane 1 – M. tuberculosis H37Rv genomic DNA, Lanes 2 and 3 – possible DCO genomic DNA. C. Agarose gel electrophoresis of PCR products from complemented strains
withM. smegmatis guaA gene. M – molecular marker 1 kb plus DNA Ladder (Invitrogen), PCRs were carried out with: Lane 1 – M. tuberculosis H37Rv genomic DNA, Lanes 2–7
– genomic DNA from complemented strains.
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iophage Ms6-based integrating vector was constructed [10]. This
strain was transformed with the pPR27xylE construction to obtain
the complemented strain, and six clones were screened for DCOs
by PCR. Of the six screened clones, all contained the guaA dis-
rupted allele (Fig. 2C). This result conﬁrmed the guaA essentiality
in M. tuberculosis, since the DCO event only occurred when an
extra copy of the gene was present.
Protein level validation of the guaA essentiality observed by
PCR (Fig. 2) was approached by shotgun proteomic analysis. Mtb-
and Msm-GMPS were identiﬁed in wild-type and complemented
cellular extracts of M. tuberculosis, respectively. Among 1666 pro-
teins detected using reversed phase peptide separation, we were
able to identify Mtb-GMPS (P9WMS7, Rv3396c) and Msm-GMPS
with 45.7% and 19.4% of sequence coverage, respectively (Fig. 3A).
The uniqueness of these peptides was conﬁrmed by a quantitative
MudPIT analysis, where peptides from wild-type and com-
plemented cellular extracts were labeled with Light and Heavy
forms of dimethylation, respectively. As an internal control, a
mixture of equal proportions of wild-type and complemented
cellular extracts was labeled with Intermediate form of dimethy-
lation. These analyses increased the sequence coverage of Mtb-
and Msm-GMPS to 51.2% and 23.0%, respectively (Fig. 3A).
The expression levels of Mtb- and Msm-GMPS in wild-type and
complemented cellular extracts were measured by the relative
abundance displayed by peptides common in both proteins. Fig. 3B
shows the precursor ions of doubly charged peptide LLFKDEVR,
shared by both proteins. The extracted ion chromatograms (XICs)
and the respective peak areas of Light, Intermediate and Heavy
forms of the peptide are shown in Fig. 3C. Using all common
peptides identiﬁed in MudPIT technical triplicates, an average ratio
of Mtb-GMPS (Light)/Msm-GMPS (Heavy) was calculated. To ac-
count for experimental inaccuracies, a global normalization factor
calculated by Census, using all peptide ratios from the entire M.
tuberculosis proteome, was used (data not shown), giving a cor-
rected ratio value for Mtb-GMPS/Msm-GMPS of 3.41.
The quantitative method employed here also allowed the
identiﬁcation of peptides unique to either Mtb- or Msm-GMPS.
Fig. 3D shows XICs of the Light, Intermediate and Heavy forms of a
Mtb-GMPS unique, triply charged peptide, QPVALVLSGGPAS-
VYADGAPK. Peak areas were calculated for each isotopic label;
Light channel presented a peak area of 8.8106 whereas the peak
area detected in the Heavy channel was not identiﬁed as the Heavy
labeled peptide, being only at noise level (7.6104), as expected.
The Intermediate peak area was 4.4106, an approximate average
between Light and Heavy areas.
In contrast, a quadruply charged Msm-GMPS unique peptide,
TELQVTGGDLHSELPATQPVWMSHGDAVTAAPEGFDVVASSA-
GAPVAGFENR, displayed detectable XIC only in the Heavy form ofthe peptide (2.1107). While a Light peak area was undetectable,
the Intermediate form was 9.1106, an approximate half of the
Heavy peak area (Fig. 3E).
The Intermediate XIC peaks of unique and common peptides
further conﬁrm the reliability of the quantitative data. The peak
area of Intermediate XICs is an experimental measurement of the
average intensity of Light and Heavy peaks. Indeed, the compar-
ison of calculated Light and Heavy average areas to the experi-
mentally obtained Intermediate area of all Mtb-GMPS/Msm-GMPS
common peptides showed an error of less than 1% (data not
shown).5. Discussion
In this report, we evaluate the essentiality of guaA by gene
replacement in M. tuberculosis H37Rv strain. GMP synthesis from
inosine 5′-monophosphate requires both IMPDH and GMPS, which
are important enzymes from the purine biosynthesis pathway.
These genes are present as independent loci in M. tuberculosis
genomic DNA while in some bacteria they are located in the same
operon. The disruption of guaA and guaB genes have been pre-
viously reported in several bacterial pathogens, resulting in atte-
nuated strains which, in some cases, were also auxotrophic for
guanine [4–6]. In contrast, the results presented here showed that
a M. tuberculosis strain containing a disrupted guaA gene could not
be isolated, which is an indication that this gene is essential for
growth. Despite the presence of hypoxantine-guanine phosphor-
ibosyltransferase enzyme in M. tuberculosis, an auxotrophic strain
for guanine could not be obtained by deleting guaA gene. The guaA
gene could only be disrupted at its native locus if a functional copy
is supplied elsewhere. Msm-GMPS complemented the function of
the correspondent Mtb enzyme, once the lethal phenotype of M.
tuberculosis guaA disruption was avoided by the expression of M.
smegmatis guaA.
In order to conﬁrm guaA essentiality at protein level, we per-
formed label-free and dimethyl labeling quantitative LC–MS/MS
analyses of wild-type and complemented cellular extracts. Al-
though Mtb- and Msm-GMPS proteins share 85.69% amino acid
sequence identity, we were able to evaluate the origin of unique
and common peptides from both proteins. Through these quanti-
tative proteomic experiments, we conﬁrmed that the com-
plemented strain contained only Msm-GMPS. Further evidence of
the origin of the unique and common peptides was obtained using
equal proportion of wild-type and complemented cellular extracts.
Peptide peak areas were expected as an average of the intensity of
those found in the wild-type and complemented samples, as
shown in Fig. 3C–E.
In addition, the method employed here allows the relative
Fig. 3. Identiﬁcation of GMPS by LC–MS/MS. (A) GMPS amino acid sequences alignment from M. tuberculosis (Mtb-GMPS) and M. smegmatis (Msm-GMPS); sequences
identiﬁed by label-free LC–MS/MS are in bold; those identiﬁed by MudPIT are underlined. (B) Mass spectrum of precursor ions of triply charged peptide LLFKDEVR; Light (left
box), Intermediate (middle box) and Heavy (right box). (C–E) Extracted ion chromatograms (XICs) and peak areas of the Light (blue), Intermediate (red) and Heavy (green)
forms of the peptides: (C) LLFKDEVR, doubly charged, common to Mtb-GMPS and Msm-GMPS; (D) QPVALVLSGGPASVYADGAPK, triply charged, unique to Mtb-GMPS;
(E) TELQVTGGDLHSELPATQPVWMSHGDAVTAAPEGFDVVASSAGAPVAGFENR, quadruply charged, unique to Msm-GMPS.
A.D. Villela et al. / Biochemistry and Biophysics Reports 4 (2015) 277–282 281quantiﬁcation of GMPS in the wild-type and in the complemented
strains. Using peptide sequences common to both Mtb- and Msm-
GMPS, we veriﬁed an approximate 3.4-fold difference in the ex-
pression levels of guaA gene in the wild-type strain compared to
the complemented strain. The reduced sequence coverage of
Msm-GMPS compared to Mtb-GMPS obtained by reversed phaseand MudPIT analyses also corroborates with the difference in ex-
pression levels. The insertion of the ortholog guaA gene in a dif-
ferent position on the mycobacterial genomic DNA, and the ex-
pression of this gene under the natural M. smegmatis promoter in
the complemented strain could explain the different expression
levels seen here.
A.D. Villela et al. / Biochemistry and Biophysics Reports 4 (2015) 277–282282Multiple sequence alignment of polypeptide chains of GMPS
enzymes showed that M. tuberculosis has high identity to prokar-
yotic proteins (47.39% with Escherichia coli) while it has a relatively
low identity to the human enzyme (15.50%) [3]. Based on sequence
alignment of primary sequences and tertiary structures, the main
differences between the monomeric eukaryotic and dimeric pro-
karyotic GMPSs rely on several large insertions in C-terminal re-
gion of eukaryotic protein, which form an additional domain that
eliminates the need for dimerization [3,22]. These differences
could be further explored to the development of speciﬁc Mtb-
GMPS inhibitors. The low identity between human and myco-
bacterial GMPS enzymes, and its essentiality in M. tuberculosis
make guaA-encoded enzyme a potential drug target. The bio-
chemical characterization of GMPS from M. tuberculosis may help
future efforts towards the development of inhibitors based on
particular features of the mycobacterial enzyme [3].
In conclusion, we showed that the disruption of the guaA gene
resulted in M. tuberculosis lethality. The complementation with a
rescue copy of this gene is required to avoid the lethal phenotype,
which was conﬁrmed at protein level via quantitative LC–MS/MS.
These results validate GMPS as a molecular target for drug design
against Mtb, and GMPS inhibitors might prove to be useful for
future development of new drugs to treat human TB.Conﬂict of interest
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